OAB CARE PATHWAY Percutaneous Tibial Neuromodulation (PTNM)
Below is an example of a typical bladder control treatment pathway for a patient who is seeking treatment for symptoms of urge-incontinence and/or urgency-frequency.1
Share this pathway with your OAB patients, regardless of where they are on the pathway, to help them understand that there is a wide range of treatment options. Seeing that there is a care pathway motivates patients to try another option when one fails or is unsatisfactory.
Gormley, EA, Lightner DJ, et al. 2015. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193(5): 1572-1580.
Kobashi K, Khandwala S, MacDiarmid S, et al. A Prospective Study to Evaluate Efficacy with the NURO Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with overactive bladder syndrome (OAB). Presented at the American Urological Association 2018 Annual Meeting. Journal of Urology. 2018;199(4) Supplement, Page e987.